<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of an HIV-infected young men with neuro-<z:e sem="disease" ids="C0040558" disease_type="Disease or Syndrome" abbrv="">toxoplasmosis</z:e> localized in the spinal cord </plain></SENT>
<SENT sid="1" pm="."><plain>The patient received chemotherapy and immunotherapy for Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> one year before </plain></SENT>
<SENT sid="2" pm="."><plain>At the time of the diagnosis of <z:e sem="disease" ids="C0040558" disease_type="Disease or Syndrome" abbrv="">toxoplasmosis</z:e>, he was on prophylaxis with <z:chebi fb="0" ids="45924">trimethoprim</z:chebi> and <z:chebi fb="0" ids="9332">sulfamethoxazole</z:chebi> and in complete remission of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The CD4+ T cell count was 270/Î¼l and the HIV <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> was undetectable </plain></SENT>
<SENT sid="4" pm="."><plain>These findings suggest that in this patient, the <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> promoting the neurologic <z:e sem="disease" ids="C0040558" disease_type="Disease or Syndrome" abbrv="">toxoplasmosis</z:e> arose more from previous immuno-chemotherapy than from the <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV-infection</z:e> itself </plain></SENT>
<SENT sid="5" pm="."><plain>On the whole, this case highlights that the risk stratification for <z:e sem="disease" ids="C0029118" disease_type="Disease or Syndrome" abbrv="">opportunistic infections</z:e> of HIV-infected patients should carefully consider their previous medical history and therapies received </plain></SENT>
</text></document>